Silicone Applications, from Elastomers to Laminates



“Thinking beyond”, that is the motto under which Wacker, the Munich-based chemical group, will be showcasing new products. These innovations include fire-resistant silicone elastomers, self-adhesive silicone rubber grades with extremely low-friction surfaces and ultrathin silicone laminates for electroactive applications. The focus will also be on liquid silicone rubber grades that, thanks to their greatly reduced volatiles content, do not necessarily require post-curing and thus unlock various advantages.
Nexipal is a novel silicone laminate with electroactive properties. It consists of several ultrathin precision silicone films that are coated with electrically conductive material prior to lamination. The result is an actuator that creates movement, as soon as electrical voltage is applied. The laminates can be used to measure mechanical deformation electrically. Thus, the product can also serve as a sensor.
ACEO Imagine Series K2 is Wacker´s latest 3D printer with real silicon. It can print up to four different silicone materials simultaneously, allowing new designs to be realized. 3D objects can now be printed in different colours and with different degrees of hardness. The new technology also benefits the printing of objects, which require support material.
most read

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.

Relocation of Chemicals Production Footprint in Full Swing
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0











